The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 30, 2018
Filed:
May. 20, 2014
Applicant:
British Columbia Cancer Agency Branch, Vancouver, CA;
Inventors:
Ryan D. Morin, Coquitlam, CA;
Marco A. Marra, Vancouver, CA;
Andrew J. Mungall, Vancouver, CA;
Martin Hirst, Delta, CA;
Maria Mendez-Lago, Madrid, ES;
Randy D. Gascoyne, Vancouver, CA;
Joseph M. Connors, Vancouver, CA;
Assignee:
British Columbia Cancer Agency Branch, Vancouver, CA;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); C07K 14/705 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C07K 14/705 (2013.01); G01N 33/57407 (2013.01); G01N 33/57426 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/156 (2013.01);
Abstract
The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods of classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the same for a mutation in one or more biomarkers.